Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp- CFTR mutation: a phase 3, open-label extension study (PERSIST)

2014 ◽  
Vol 2 (11) ◽  
pp. 902-910 ◽  
Author(s):  
Edward F McKone ◽  
Drucy Borowitz ◽  
Pavel Drevinek ◽  
Matthias Griese ◽  
Michael W Konstan ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Extension Study ◽  
Open Label ◽  
Phase 3 ◽  
Safety And Efficacy ◽  
Open Label Extension

MP31-01 LONG-TERM SAFETY AND EFFICACY OF SER120 1.5 MCG IN PATIENTS WITH NOCTURIA: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY

2017 ◽  
Vol 197 (4S) ◽  
Author(s):  
Scott MacDiarmid ◽  
J.P. Nicandro ◽  
Maria Cheng ◽  
Steven Abrams ◽  
Seymour Fein ◽  
...  
Keyword(s):  
Extension Study ◽  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Extension

Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study

2019 ◽  
Vol 80 (1) ◽  
pp. 60-69.e2 ◽  
Author(s):  
Christos C. Zouboulis ◽  
Martin M. Okun ◽  
Errol P. Prens ◽  
Robert Gniadecki ◽  
Peter A. Foley ◽  
...  
Keyword(s):  
Hidradenitis Suppurativa ◽  
Extension Study ◽  
Acne Inversa ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Extension
Sign in / Sign up

Export Citation Format

Share Document